Literature DB >> 23877383

The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces.

Osman Raif Karabacak1, Demet Yilmazer, Ufuk Ozturk, Nevzat Can Sener, Hakan Saltas, Yurdum Karabacak, Murat Alper.   

Abstract

In this study, we aimed to demonstrate the presence of Alpha (α) 1 receptors and subtypes in human pelvis and calyces, because an agent to facilitate kidney stone movement and help decrease pain may be an α 1 adrenergic blocker, as used in ureteral stones. Twenty patients who applied to our clinic for renal cell carcinoma were enrolled to the study. All patients underwent radical nephrectomy. After the specimens were removed, excisional biopsies were performed on healthy pelvises and calyces. Mean α-receptor stain rates in renal pelvis were 2.65 ± 0.74, 1.35 ± 0.81 and 2.9 ± 0.30 for α 1A, 1B and 1D, respectively. For calyces, the rates are 2.40 ± 0.82, 1.50 ± 0.76 and 2.75 ± 0.44 for α 1A, 1B and 1D, respectively (Fig. 1). When the staining patterns were compared, α 1A and 1D were expressed more in both pelvis and calyces than α 1B (p < 0.05). After the demonstration of α-adrenergic receptors in pelvis and calyces of human kidney, it may be helpful in coming up with new alternative treatments for patients suffering from kidney stones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23877383     DOI: 10.1007/s00240-013-0592-5

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  17 in total

1.  Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi?

Authors:  Siavash Falahatkar; Iradj Khosropanah; Anahita Doustkhah Vajary; Zhoobin Heidari Bateni; Darya Khosropanah; Aliakbar Allahkhah
Journal:  J Endourol       Date:  2010-12-18       Impact factor: 2.942

2.  Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial.

Authors:  Osama M Zaytoun; Rachid Yakoubi; Abdel Rahman M Zahran; Khaled Fouda; Essam Marzouk; Salah Gaafar; Khaled Fareed
Journal:  Urol Res       Date:  2011-08-12

3.  Potassium and ANO1/ TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvis.

Authors:  Javed Iqbal; Mary A Tonta; Retsu Mitsui; Qun Li; Michelle Kett; Jinhua Li; Helena C Parkington; Hikaru Hashitani; Richard J Lang
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Medical therapy to facilitate the passage of stones: what is the evidence?

Authors:  Christian Seitz; Evangelos Liatsikos; Francesco Porpiglia; Hans-Göran Tiselius; Ulrike Zwergel
Journal:  Eur Urol       Date:  2009-06-21       Impact factor: 20.096

5.  Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

Authors:  Shinya Kobayashi; Yoshitaka Tomiyama; Kazuyasu Maruyama; Yuji Hoyano; Yoshinobu Yamazaki; Hiroshi Kusama
Journal:  J Smooth Muscle Res       Date:  2009-08

6.  A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra.

Authors:  Y Kunisawa; K Kawabe; T Niijima; K Honda; T Takenaka
Journal:  J Urol       Date:  1985-08       Impact factor: 7.450

7.  The use of alpha-blockers for the treatment of nephrolithiasis.

Authors:  Michael Lipkin; Ojas Shah
Journal:  Rev Urol       Date:  2006

8.  Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter.

Authors:  Hyoung Keun Park; Eun Young Choi; Byong Chang Jeong; Hyeon Hoe Kim; Byoung Kwon Kim
Journal:  Urol Res       Date:  2007-11-01

9.  An in vitro study on human ureteric smooth muscle with the alpha1-adrenoceptor subtype blocker, tamsulosin.

Authors:  John Rajpathy; Karthikeyan Aswathaman; Maneesh Sinha; Sathya Subramani; Ganesh Gopalakrishnan; Nitin S Kekre
Journal:  BJU Int       Date:  2008-09-03       Impact factor: 5.588

10.  Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?

Authors:  Suresh K Bhagat; Ninan K Chacko; Nitin S Kekre; Ganesh Gopalakrishnan; Belavendra Antonisamy; Antony Devasia
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  4 in total

Review 1.  Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Authors:  M Archer; N Dogra; Z Dovey; T Ganta; H-S Jang; J A Khusid; A Lantz; M Mihalopoulos; J A Stockert; A Zahalka; L Björnebo; S Gaglani; M R Noh; S A Kaplan; R Mehrazin; K K Badani; P Wiklund; K Tsao; D J Lundon; N Mohamed; F Lucien; B Padanilam; M Gupta; A K Tewari; N Kyprianou
Journal:  Cell Commun Signal       Date:  2021-07-20       Impact factor: 5.712

2.  Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based study.

Authors:  Chia-Chu Liu; Hui-Min Hsieh; Chia-Fang Wu; Tusty-Jiuan Hsieh; Shu-Pin Huang; Yii-Her Chou; Chun-Nung Huang; Wen-Jeng Wu; Ming-Tsang Wu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

3.  Altered expression profile of renal α(1D)-adrenergic receptor in diabetes and its modulation by PPAR agonists.

Authors:  Xueying Zhao; Yuanyuan Zhang; Michelle Leander; Lingyun Li; Guoshen Wang; Nerimiah Emmett
Journal:  J Diabetes Res       Date:  2014-03-17       Impact factor: 4.011

4.  Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.

Authors:  Makinna C Oestreich; Robin Wm Vernooij; Niranjan J Sathianathen; Eu Chang Hwang; Gretchen M Kuntz; Alex Koziarz; Charles D Scales; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.